ENTRY       D00399                      Drug
NAME        Valproic acid (USP);
            Depakene (TN)
PRODUCT
  GENERIC   VALPROIC (Actavis Pharma)
            VALPROIC (Aphena Pharma Solutions - Tennessee)
            VALPROIC (Bryant Ranch Prepack)
            VALPROIC ACID (ATLANTIC BIOLOGICALS CORP.)
            VALPROIC ACID (ATLANTIC BIOLOGICALS CORP.)
            VALPROIC ACID (Akorn)
            VALPROIC ACID (American Health Packaging)
            VALPROIC ACID (Aphena Pharma Solutions - Tennessee)
            VALPROIC ACID (Aphena Pharma Solutions - Tennessee)
            VALPROIC ACID (Bionpharma)
            VALPROIC ACID (Bryant Ranch Prepack)
            VALPROIC ACID (Bryant Ranch Prepack)
            VALPROIC ACID (Chartwell RX)
            VALPROIC ACID (Direct_Rx)
            VALPROIC ACID (Eywa Pharma)
            VALPROIC ACID (Lannett Company)
            VALPROIC ACID (McKesson Corporation dba SKY Packaging)
            VALPROIC ACID (McKesson Corporation dba SKY Packaging)
            VALPROIC ACID (NCS HealthCare of KY)
            VALPROIC ACID (NuCare Pharmaceuticals)
            VALPROIC ACID (PAI Holdings)
            VALPROIC ACID (Precision Dose)
            VALPROIC ACID (REMEDYREPACK)
            VALPROIC ACID (REMEDYREPACK)
            VALPROIC ACID (REMEDYREPACK)
            VALPROIC ACID (Upsher-Smith Laboratories)
FORMULA     C8H16O2
EXACT_MASS  144.115
MOL_WEIGHT  144.2114
CLASS       Cardiovascular agent
             DG01575  Calcium channel blocker
              DG01573  Calcium channel T type blocker
            Neuropsychiatric agent
             DG03199  Antiepileptic agent
              DG02035  Fatty acid antiepileptic
REMARK      Same as: C07185
            ATC code: N03AG01
            Chemical structure group: DG00849
            Product (DG00849): D00399<US> D00304<US> D00710<JP/US>
EFFICACY    Anticonvulsant
COMMENT     Fatty acid derivative
            Valproic acid is contraindicated in patients with known urea cycle disorders [DS:H00164 H00185 H00186 H00187 H01028 H01032]
TARGET      ABAT [HSA:18] [KO:K13524]
            SSADH [HSA:7915] [KO:K00139]
            GAD [HSA:2571 2572] [KO:K01580]
            CACNA1-T [HSA:8911 8912 8913] [KO:K04856 K04855 K04854]
  PATHWAY   hsa04020(8911+8912+8913)  Calcium signaling pathway
            hsa04727(18+2571+2572)  GABAergic synapse
INTERACTION  
STR_MAP     map07033  Anticonvulsants
            map07036  Calcium channel blocking drugs
            map07048  Antimigraines
OTHER_MAP   map00982  Drug metabolism - cytochrome P450
BRITE       Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
             N NERVOUS SYSTEM
              N03 ANTIEPILEPTICS
               N03A ANTIEPILEPTICS
                N03AG Fatty acid derivatives
                 N03AG01 Valproic acid
                  D00399  Valproic acid (USP) &lt;US&gt;
            USP drug classification [BR:br08302]
             Anticonvulsants
              Anticonvulsants, Other
               Valproic Acid
                D00399  Valproic acid (USP)
             Antimigraine Agents
              Antimigraine Agents, Other
               Valproic Acid
                D00399  Valproic acid (USP)
             Bipolar Agents
              Mood Stabilizers
               Valproic Acid
                D00399  Valproic acid (USP)
            Drug groups [BR:br08330]
             Cardiovascular agent
              DG01575  Calcium channel blocker
               DG01573  Calcium channel T type blocker
                DG00849  Valproic acid
                 D00399  Valproic acid
             Neuropsychiatric agent
              DG03199  Antiepileptic agent
               DG02035  Fatty acid antiepileptic
                DG00849  Valproic acid
                 D00399  Valproic acid
            Drug classes [BR:br08332]
             Neuropsychiatric agent
              DG03199  Antiepileptic agent
               D00399  Valproic acid
            Target-based classification of drugs [BR:br08310]
             Ion channels
              Voltage-gated ion channels
               Calcium channels
                CACNA1-T
                 D00399  Valproic acid (USP) &lt;US&gt;
             Enzymes
              Oxidoreductases (EC1)
               Dehydrogenases
                SSADH
                 D00399  Valproic acid (USP) &lt;US&gt;
              Transferases (EC2)
               Aminotransferase
                ABAT
                 D00399  Valproic acid (USP) &lt;US&gt;
              Lyases (EC4)
               Carboxy-lyases
                GAD
                 D00399  Valproic acid (USP) &lt;US&gt;
            Pharmacogenomic biomarkers [br08341.html]
             Polymorphisms and mutations affecting drug response
              D00399
            Drug groups [BR:br08330]
             Cardiovascular agent
              DG01575  Calcium channel blocker
               DG01573  Calcium channel T type blocker
                DG00849  Valproic acid
             Neuropsychiatric agent
              DG03199  Antiepileptic agent
               DG02035  Fatty acid antiepileptic
                DG00849  Valproic acid
DBLINKS     CAS: 99-66-1
            PubChem: 7847465
            ChEBI: 39867
            PDB-CCD: 2PP
            LigandBox: D00399
            NIKKAJI: J4.972G
ATOM        10
            1   C1c C    25.4573  -18.6784
            2   C1b C    25.4573  -17.3002
            3   C1b C    24.2485  -19.3967
            4   C6a C    26.6604  -19.3967
            5   C1b C    24.2427  -16.5935
            6   C1b C    23.0396  -18.6784
            7   O6a O    26.6604  -20.7925
            8   O6a O    27.8692  -18.6784
            9   C1a C    23.0339  -17.3002
            10  C1a C    21.8367  -19.3967
BOND        9
            1     1   2 1
            2     1   3 1
            3     1   4 1
            4     2   5 1
            5     3   6 1
            6     4   7 1
            7     4   8 2
            8     5   9 1
            9     6  10 1
///
